Evidence map›Paper›PMID 22844459›Full record

ArticlePloS one2012

Activation of soluble adenylyl cyclase protects against secretagogue stimulated zymogen activation in rat pancreaic acinar cells.

Thomas R Kolodecik, Christine A Shugrue, Edwin C Thrower, Lonny R Levin, Jochen Buck, Fred S Gorelick

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. CaCold Spring Harbor perspectives in biology · 2020
    Review
  4. Review
  5. Pharmacological modulation of the COPharmacology & therapeutics · 2018
    Review
  6. Review
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Thomas R KolodecikSection of Digestive Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America.
Christine A Shugrue
Edwin C Thrower
Lonny R Levin
Jochen Buck
Fred S Gorelick
VA Connecticut Healthcare System · USCornell University · USYale University · US

Funding

BICARBONATE REGULATED ADENYLYL CYCLASER01GM062328 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI BUCK, JOCHEN, LEVIN, LONNY R · 2001 to 2013
$4.6M
EXOCRINE PANCREATIC ZYMOGEN ACTIVATIONR01DK054021 · NIDDK · YALE UNIVERSITY · PI GORELICK, FRED SANFORD · 1998 to 2018
$3.6M
Soluble adenylyl cyclase isoforms essential for male fertilityR01HD059913 · NICHD · WEILL MEDICAL COLL OF CORNELL UNIV · PI BUCK, JOCHEN, LEVIN, LONNY R · 2009 to 2013
$1.7M
Neuronal growth factor signaling via cAMPR01NS055255 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI LEVIN, LONNY R · 2007 to 2010
$1.5M
SOLUBLE ADENYLYL CYCLASE ACTIVITY IN MALE GERM CELLSR01HD038722 · NICHD · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI LEVIN, LONNY R · 2001 to 2004
$1.2M
NICHD NIH HHS R01 HD038722NICHD NIH HHS R01 HD059913NIDDK NIH HHS R01 DK054021NIDDK NIH HHS R01 DK-54021NIGMS NIH HHS R01 GM062328NINDS NIH HHS R01 NS055255
6 · The paper itself

Abstract

An early feature of acute pancreatitis is activation of zymogens, such as trypsinogen, within the pancreatic acinar cell. Supraphysiologic concentrations of the hormone cholecystokinin (CCK; 100 nM), or its orthologue cerulein (CER), induce zymogen activation and elevate levels of cAMP in pancreatic acinar cells. The two classes of adenylyl cyclase, trans-membrane (tmAC) and soluble (sAC), are activated by distinct mechanisms, localize to specific subcellular domains, and can produce locally high concentrations of cAMP. We hypothesized that sAC activity might selectively modulate acinar cell zymogen activation. sAC was identified in acinar cells by PCR and immunoblot. It localized to the apical region of the cell under resting conditions and redistributed intracellularly after treatment with supraphysiologic concentrations of cerulein. In cerulein-treated cells, pre-incubation with a trans-membrane adenylyl cyclase inhibitor did not affect zymogen activation or amylase secretion. However, treatment with a sAC inhibitor (KH7), or inhibition of a downstream target of cAMP, protein kinase A (PKA), significantly enhanced secretagogue-stimulated zymogen activation and amylase secretion. Activation of sAC with bicarbonate significantly inhibited secretagogue-stimulated zymogen activation; this response was decreased by inhibition of sAC or PKA. Bicarbonate also enhanced secretagogue-stimulated cAMP accumulation; this effect was inhibited by KH7. Bicarbonate treatment reduced secretagogue-stimulated acinar cell vacuolization, an early marker of pancreatitis. These data suggest that activation of sAC in the pancreatic acinar cell has a protective effect and reduces the pathologic activation of proteases during pancreatitis.

Indexed as

Acinar CellsAdenylyl CyclasesAmylasesAnimalsBicarbonatesBiomarkersCell MembraneCeruletideCholecystokininCyclic AMPCyclic AMP-Dependent Protein KinasesCytosolEnzyme ActivationEnzyme PrecursorsMalePancreasAdenylyl CyclasesAmylasesBicarbonatesBiomarkersCeruletideCholecystokininCyclic AMPCyclic AMP-Dependent Protein KinasesEnzyme PrecursorsProtein Kinase Inhibitors

Identifiers

PMID22844459
PMCPMC3402497
OpenAlexW1995059934

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.